Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Mirja Harms1, Nikaïa Smith1,2,3, Mingyu Han3

  • 1Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.

Science Advances
|July 5, 2023
PubMed

Insights

Semen contains spermine, a compound that blocks CXCR4-tropic (X4) HIV-1 infection. This finding suggests that seminal spermine naturally restricts sexual transmission of X4 HIV-1, while not affecting CCR5-tropic (R5) HIV-1.

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Semen is a primary vector for sexual HIV-1 transmission.
  • CCR5-tropic (R5) HIV-1 typically causes systemic infection, while CXCR4-tropic (X4) HIV-1 is less common in systemic infections post-transmission.
  • Factors limiting X4 HIV-1 sexual transmission are not fully understood.

Purpose of the Study:

  • To identify compounds in seminal fluid that inhibit sexual HIV-1 transmission.
  • To investigate the differential effects of seminal compounds on X4 and R5 HIV-1 strains.

Main Methods:

  • Generation and screening of a seminal fluid-derived compound library for antiviral activity.
  • Identification of active fractions containing polyamines, specifically spermine and spermidine.
  • Assays to determine the inhibitory effects of spermine on cell-free and cell-associated X4 and R5 HIV-1 infection.

Main Results:

  • Four fractions blocked X4 HIV-1 but not R5 HIV-1 infection.
  • These active fractions were found to contain spermine and spermidine.
  • Spermine, present in semen at high concentrations (up to 14 mM), binds CXCR4 and selectively inhibits X4 HIV-1 infection at micromolar concentrations.

Conclusions:

  • Seminal fluid contains factors that can restrict HIV-1 transmission.
  • Spermine is identified as a key component that selectively inhibits X4 HIV-1 infection.
  • Seminal spermine likely plays a role in limiting sexual transmission of X4 HIV-1.